Stereospecific and structure-dependent insulin-mimetic oxovanadium(IV) complexes with N,N'-ethylenebis(amino acids) [4]

Journal of the American Chemical Society

Volumn 121, Issue 34, 1999, Pages 7937-7938

  Kawabe, Kenji ^a   Tadokoro, Makoto ^a   Ichimura, Akio ^a   Kojima, Yoshitane ^a   Takino, Toshikazu ^b   Sakurai, Hiromu ^b  

^a Osaka Prefecture University   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; ANTIDIABETIC AGENT; FATTY ACID; INSULIN; VANADIUM DERIVATIVE;

CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; DRUG STRUCTURE; GLUCOSE TRANSPORT; LETTER; LIPOPHILICITY; PARTITION COEFFICIENT; STEREOSPECIFICITY; STREPTOZOCIN DIABETES; STRUCTURE ACTIVITY RELATION; X RAY ANALYSIS;

EID: 0033199131     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja984225+     Document Type: Letter

References (30)

1. (a) Sakurai, H.; Tsuji, A. In Vanadium in the Environment; Nriagu, J. O., Ed.; Wiley: New York, 1998; p 297.
2. (b) Sakurai, H.; Fujii, K.; Fujimoto, S.; Fujisawa, Y.; Takechi, K.; Yasui, H. In Vanadium Compounds: Chemistry, Biochemistry, and Therapeutic Applications; ACS Symposium Series 711; Tracey, A. S., Crans, D. C., Eds.; American Chemical Society: Washington, DC, 1998; p 344.
3. Caravan, P.; Gelmini, L.; Glover, N.; Herring, F. G.; Li, H.; McNeill, J. H.; Rettig, S. J.; Setyawati, I. A.; Shuter, E.; Sun, Y.; Tracey, A. S.; Yuen, V. G.; Orvig, C. J. Am. Chem. Soc. 1995, 117, 12759.
4. Sakurai, H.; Watanabe, H.; Tamura, H.; Yasui, H. Inorg. Chim. Acta 1998, 283, 175.
5. Tawa, R.; Uchida, K.; Taniyama, J.; Fujisawa, Y.; Fujimoto, S.; Nagaoka, T.; Kanamori, K.; Sakurai, H. J. Pharm. Pharmacol. 1999, 50, 1.
6. Cohen, N.; Halberstam, M.; Shlimovich, P.; Chang, C. J.; Shamoon, H.; Rossetti, L. J. Clin. Invest. 1995, 95, 2501.
7. Goldfine, A. B.; Simonson, D. C.; Folli, F.; Patti, M. E.; Kahn, C. R. J. Clin. Endocrinol. Metab. 1995, 80, 3311.
8. Goldfine, A. B.; Simonson, D. C.; Folli, F.; Patti, M. E.; Kahn, C. R. Mol. Cell Biochem. 1995, 153, 217.
9. Halberstam, M.; Cohen, N.; Shlimovich, P.; Rossetti, L.; Shamoon, H. Diabetes 1996, 45, 659.
10. Boden, G.; Chen, X.; Ruiz, J.; van Rossum, G. D. V.; Turco, S. Metabolism 1996, 45, 1130.
11. Sakurai, H.; Fujii, K.; Watanabe, H.; Tamura, H. Biochem. Biophys. Res. Commun. 1995, 214, 1095.
12. Fujimoto, S.; Fujii, K.; Yasui, H.; Matsushita, R.; Takada, J.; Sakurai, H. J. Clin. Biochem. Nutr. 1997, 23, 113.
13. Sakurai, H.; Fujisawa, Y.; Yasui, H.; Fujimoto, S. 33th Int. Conf. Coord. Chem. 1998, Abstract 614.
14. Kawabe, K.; Tadokoro, M.; Kojima, Y.; Fujisawa, Y.; Sakurai, H. Chem. Lett. 1998, 9.
15. Shechter, Y.; Shisheva, A.; Lazar, R.; Libman, J.; Shanzer, A. Biochemistry 1992, 31, 2063.
16. Watanabe, M.; Kojima, Y.; Kawabe, K.; Hatamoto, E.; Tsuru, E.; Miyake, H.; Yamashita, T. Synthesis 1996, 452.
17. w are the equilibrium concentrations of the complex in n-octanol and saline, respectively, after shaking for 2 h at 37°C.
18. 2O achieved by using 3761 reflections and 164 variable parameters. Details of X-ray crystallographic analyses are in Supporting Information.
19. The molecular structures of complexes 3, 5, and 9 and the CD spectra of the complexes 3-10 in water are available as Supporting Information. The detailed results and discussions of these studies will be reported elsewhere.
20. w = 0.038 (1 > 3.00 σ(I)) for 8 achieved by using 1602 reflections and 293 variable parameters. Details of X-ray crystallographic analyses are in Supporting information.
21. Nakai, M.; Watanabe, H.; Fujiwara, C.; Kakegawa, H.; Satoh, T.; Takada, J.; Matsushita, R.; Sakurai, H. Biol. Pharm. Bull. 1995, 18, 719.
22. Dubyak, G. R.; Kleinzeller, A. J. Biol. Chem. 1980, 255, 5306.
23. Sakurai, H.; Tsuchiya, K.; Nukatsuka, M.; Sofue, M.; Kawada, J. J. Endocrinol. 1990, 126, 451.
24. Duckworth, W. C.; Solomon, S. S.; Liepnieks, J.; Hamel, F. G.; Hand, S.; Peavy, D. E. J. Endocrinol. 1988, 122, 2285.
25. Fantus, I. G.; Ahmad, F.; Deragon, D. J. Endocrinol. 1990, 127, 2716.
26. 50 values are expressed on the basis of the concentration of oxovanadium(IV) complex to inhibit 50% of the FFA released from the adipocytes.
27. The correlation coefficient of the linear regression was greater than 0.966 for a total of four points (complexes 3, 5, 7, and 9) in the triplicated measurements. However, this coefficient was greater than 0.687 for a total of four points (complexes 4, 6, 8, and 10).
28. Bevan, A. P.; Burgess, J. W.; Yale, J.-F.; Drake, P. A.; Lachance, D.; Baquiran, G.; Shaver, A.; Posner, B. I. Am. J. Physiol. 1995, 268, E60.
29. Martell, A. E.; Smith, R. M. Critical Stability Constants; Plenum Press: New York, 1974; p 1.
30. Redox potentials with respect to Ag/AgCl were electrochemically measured at a glassy carbon electrode in 0.1 M phosphate buffer (pH 7.0).